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Antibiofilm activity of flavonoids 
on staphylococcal biofilms 
through targeting BAP amyloids
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Alex Mira3, Iñigo Lasa2 & Jaione Valle1*
The opportunistic pathogen Staphylococcus aureus is responsible for causing infections related to 
indwelling medical devices, where this pathogen is able to attach and form biofilms. The intrinsic 
properties given by the self‑produced extracellular biofilm matrix confer high resistance to antibiotics, 
triggering infections difficult to treat. Therefore, novel antibiofilm strategies targeting matrix 
components are urgently needed. The Biofilm Associated Protein, Bap, expressed by staphylococcal 
species adopts functional amyloid‑like structures as scaffolds of the biofilm matrix. In this work we 
have focused on identifying agents targeting Bap‑related amyloid‑like aggregates as a strategy to 
combat S. aureus biofilm‑related infections. We identified that the flavonoids, quercetin, myricetin 
and scutellarein specifically inhibited Bap‑mediated biofilm formation of S. aureus and other 
staphylococcal species. By using in vitro aggregation assays and the cell‑based methodology for 
generation of amyloid aggregates based on the Curli‑Dependent Amyloid Generator system (C‑DAG), 
we demonstrated that these polyphenols prevented the assembly of Bap‑related amyloid‑like 
structures. Finally, using an in vivo catheter infection model, we showed that quercetin and myricetin 
significantly reduced catheter colonization by S. aureus. These results support the use of polyphenols 
as anti‑amyloids molecules that can be used to treat biofilm‑related infections.
Staphylococcus aureus is one of the leading bacteria causing biofilm‐associated infections related with medical 
 devices1. The difficulty of treating such infections is aggravated by the intrinsic resistance to antibiotics given 
by the biofilm structures produced by these  bacteria2–4. Therefore, to fight against biofilm-associated infections, 
investigations have focused on antibiofilm agents targeting the matrix components, so bacteria lose the protec-
tion of the matrix, thereby increasing the effectiveness of traditional antibiotic  therapies5–8.
Staphylococcus aureus produces a biofilm matrix composed of exopolysaccharides, surface proteins, extracel-
lular DNA and functional  amyloids9–14. Two types of amyloids have been described as scaffold biofilm matrix of 
S. aureus. The first group consists of small peptides known as phenol-soluble modulins (PSMs)13. These peptides 
show a tendency to aggregate in amyloid fibers that contribute to the stabilization and maturation of the biofilm 
structure by preventing disassembly of the biofilm matrix. The second type of staphylococcal amyloids is the 
group of facultative amyloids. This group comprises surface-associated proteins that adopt an amyloid-like 
conformation under specific environmental conditions, as the Biofilm Associated Protein (Bap) present in some 
strains of S. aureus and in other coagulase negative  staphylococci15–17.
Bap is a multidomain secreted protein identified in a transposon-based mutagenesis for the screening of bio-
film defective mutants in the bovine mastitis isolate S. aureus  V32918. Bap promotes biofilm formation through a 
mechanism that is independent of the biofilm associated polysaccharide PNAG. The bap gene is frequently identi-
fied in mastitis-derived staphylococcal species and all the isolates expressing Bap are strong biofilm  formers19.
Bap undergoes partial proteolytic cleavage, which releases fragments containing the N-terminal  region17. 
This region has a molten globule-like conformation that, when the pH becomes acidic, switches to a β-sheet-rich 
structure and forms amyloid-like  fibers17. Others Bap homologs behave the same way. The cleavage of N-terminal 
domain is enough for the formation of amyloid  fibers17,20. However, in S. epidermidis, the C-repeat domain 
contains amyloid peptides that are sufficient for spontaneous formation of amyloid  fibers21. This makes Bap an 
excellent target for anti-amyloid compounds to reduce staphylococcal biofilm formation.
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Polyphenols are natural small molecules composed of one or more aromatic phenolic rings. Because of 
their antioxidant, anti-platelet and anti-inflammatory effects they appear to have disease-fighting properties 
including neurological and cardiovascular  diseases22–25. In some neurodegenerative disorders related to amy-
loids, polyphenols inhibit toxic amyloids assembly or remove already formed amyloid oligomers and  fibrils26,27. 
Polyphenols are also effective against viral and bacterial  infections28–32. In this context, it has been proposed 
that the antibacterial mechanisms of polyphenols can be related to their ability to inhibit biofilm formation or 
to disperse already pre-formed  biofilms33.
Here, we evaluated the efficacy of a set of polyphenolic molecules with demonstrated anti-amyloid effect on 
human amyloids to inhibit Bap-mediated biofilm formation. We identified that specifically the flavonoids querce-
tin, myricetin and scutellarein inhibited biofilms of several S. aureus strains and other staphylococcal species 
expressing Bap. We demonstrated that polyphenols specifically inhibit Bap amyloid-like aggregates. Finally, by 
using a catheter infection model in mice we showed that quercetin and myricetin reduced catheter-colonization 
by S. aureus. Our results enlighten the potential of polyphenols as promising candidates for inhibiting S. aureus 
biofilms.
Results
Screening for polyphenols with antibiofilm activity against amyloid‑mediated biofilm. We 
choose a collection of polyphenolic compounds, including flavonoids, stilbenoids and phenolic acids, that have 
been shown to inhibit fibrillization of human and bacterial amyloids with the aim of identifying polyphenols 
targeting Bap amyloid-like aggregates (Table 1 and Fig. S1)27,34. First, we determined the minimum inhibitory 
concentrations (MIC) of selected polyphenols against S. aureus V329 using the standard broth microdilution 
method (Table 1). MIC against S. aureus V329 were 375 μg/ml for curcumin, 500 μg/ml for quercetin, scutel-
larein and genistein, 750 μg/ml for eriodictyol, 1000 μg/ml for myricetin, baicalein and resveratrol and 2500 μg/
ml for gallic acid. Next, we tested the antibiofilm effect of the polyphenols on S. aureus V329 biofilm adminis-
tered at sub-MIC dosages. As expected none of the polyphenols at the concentrations tested affected bacterial 
viability (Fig. S2). In order to identify polyphenols that specifically inhibit Bap-dependent biofilm formation, we 
included the S. aureus 15981 strain (bap negative), which formed a polysaccharide (PNAG)-dependent biofilm, 
as a control. After cultivation of S. aureus V329 and 15981 strains in the presence of 1/50xMIC, 1/100xMIC and 
1/500xMIC of the polyphenols, biofilms were stained with crystal violet. Results showed that myricetin (MC), bai-
calein (BC), and scutellarein (SC) strongly inhibited biofilm formation of S. aureus V329 at 1/50xMIC (MC 20 μg/
ml, BC 20 μg/ml and SC 10 μg/ml) with a percentage of biofilm inhibition of 94% ± 1%, 91% ± 3%, 92% ± 3%, 
respectively and 1/100xMIC (MC 10 μg/ml, BC 10 μg/ml and SC 5 μg/ml) with a percentage of biofilm reduction 
of 92% ± 4%, 69% ± 21%, 84% ± 1%, respectively (***P < 0.001, **P < 0.01, *P < 0.05) (Fig. 1A,B). Quercetin (QC) 
significantly reduced biofilm at 1/50xMIC (10 μg/ml) with a percentage of biofilm inhibition of 75 ± 2 (**P < 0.01). 
Only genistein (GN) (10 μg/ml) and baicalein (BC) (20 μg/ml) significantly reduced biofilm of S. aureus 15981 
(**P < 0.01, *P < 0.05) (Fig. 1A,B). With these results, we have established that the minimal biofilm inhibitory 
concentrations (MBIC) of polyphenols to inhibit biofilms in which Bap is a matrix component are 10 μg/ml for 
QC, 10 μg/ml for MC and 5 μg/ml for SC, respectively. 
To confirm that QC, MC and SC inhibited Bap-dependent biofilm formation we analyzed the antibiofilm 
activity of the polyphenols against 3 non-related S. aureus strains that express Bap (Newman-Bap, C104 and 
V858). Quantification of the biofilm formed by these strains after incubation with polyphenols showed a sig-
nificant reduction of the bacteria adhered to the microtiter plate (Fig. 2) (***P < 0.001). We next analyzed the 
effect of the polyphenols against the biofilm formed by Bap-producing coagulase negative staphylococcal spe-
cies S. hyicus, S. saprophyticus and S. simiae. The results showed that QC, MC and SC reduced biofilm formed 
by the staphylococcal species, even though their effect was not as strong as the effect observed on the S. aureus 
Table 1.  Polyphenols used in this study. MIC Minimum inhibitory concentration, MBIC-Bap Minimum 
biofilm inhibitory concentration.
MIC (μg/ml) MBIC-Bap (μg/ml)
Flavonoids
Quercetin (QC) 500 10
Myricetin (MC) 1000 10
Baicalein (BC) 1000 10
Scutellarein (SC) 500 5
Eriodictyol (ER) 750 –
Genistein (GN) 500 –
Phenolic acids
Gallic acid (AG) 2500 –
Stilbenoids
Resveratrol (RV) 1000 –
Others
Curcumin (CC) 375 –
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Figure 1.  Inhibitory effect of polyphenols in the biofilm formation assay. (a) Biofilm formed by S. aureus V329 
(amyloid-based biofilm) and S. aureus 15981 (polysaccharide-based biofilm) in the presence of sub-MICs 
concentrations of polyphenols (1/500; 1/100; 1/50). The bacterial cells were stained with crystal violet. 2% of 
DMSO was added as control (Ø). Bacteria cultured in TSB-glu media were used as positive control (−). (b) 
Quantification of the crystal violet after addition of 200 μl of ethanol-acetone and determination of absorbance 
at 595 nm. S. aureus V329 (white bars). S. aureus 15981 (grey bars). The error bars represent the standard 
deviation of the results of three repetitions. Statistical significance was determined with one-way ANOVA 
followed by multiple comparison test (*P < 0.05; **P < 0.01; ***P < 0.001). QC Quercetin, MC myricetin, BC 
baicalein, SC scutellarein, ER eriodictyol, GN genistein, AG gallic acid, RV resveratrol, CC curcumin.
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strains (*P < 0.05;**P < 0.01;***P < 0.001) (Fig. 2). Taken together, these results indicated that the QC, MC and 
SC polyphenols prevent biofilm formation in Bap-producing staphylococcal strains.
Real‑time analysis of the antibiofilm effect of the polyphenols on S. aureus. We used the xCEL-
Ligence impedance system to quantitatively evaluate the antibiofilm effect of the polyphenols on the S. aureus 
strains V329 and 15981 on real-time. When the polyphenols QC, MC, BC and SC were added into the culture 
medium at the MBIC (10 μg/ml for QC, MC, BC, and 5 μg/ml for SC, respectively), a significant reduction in 
the biofilm mass of S. aureus V329 was observed. Specifically, QC, MC, BC and SC inhibited S. aureus V329 
biofilm formation by 37% ± 0.25%, 39% ± 0.09%, 58% ± 0.19% and 50% ± 0.23%, respectively (Fig. 3A). Interest-
ingly, inhibition of the biofilm formation capacity persisted after 48 h of growth, with significant reductions in 
the Cell Index (CI), a measure of total biofilm mass, of 33% ± 0.22% for QC, 39% ± 0.25% for MC, 58% ± 0.1% for 
BC and 58% ± 0.08% for SC (*P < 0.05) (Fig. 3A). In the case of S. aureus 15981, the addition of QC, MC and SC 
resulted in a biofilm growth delay that did not cause a significant reduction in the CI values after 48 h of growth 
(Fig. 3B). Only BC inhibited biofilm formation of 15981 by approximately 27% ± 0.37% and 18% ± 0.42% at 24 h 
and 48 h of biofilm growth respectively (Fig. 3B). Altogether, these results confirm that the polyphenols QC, MC 
and SC have a strong and specific capacity to inhibit Bap mediated biofilms, while BC is capable to prevent both 
the proteinaceous and polysaccharidic biofilm formation process.
Effect of polyphenols on Bap expression. We next evaluated whether the expression of the bap gene 
was affected by the presence of the polyphenols. We constructed a S. aureus V329-Pbap strain, harboring a tran-
scriptional fusion between bap promoter and gfpmut2 expressed in plasmid pCN52. Western blot using anti-
GFP specific antibodies revealed that the addition of MBIC of QC, MC and SC did not affect bap promoter 
expression (Fig. 4A). Alternatively, polyphenols could inhibit biofilm development by reducing the amount of 
Bap anchored to the bacterial surface. Thus, we analyzed the levels of the Bap protein of the cell surface frac-
tion of S. aureus V329 grown until exponential phase in the presence of MBICs of the polyphenols. Western 
immunoblotting using anti-Bap antibodies showed the same levels of Bap in all the samples (Fig. 4B). Since 
polyphenols did not affect Bap expression, we hypothesized that they might inhibit biofilm formation by physi-
cally interfering with the capacity of Bap to form amyloid aggregates. To evaluate this hypothesis, we monitored 
Bap aggregation using native gel electrophoresis of S. aureus V329 cells in the presence of QC, MC and SC, 
grown until late stationary phase which is the growth stage where the Bap amyloid-like aggregates are formed 
17. Western immunoblotting showed the presence of several bands of high molecular weight (~ 1000 kDa) cor-
responding to Bap aggregates in the absence of polyphenols. The amount of aggregates was lower when bacteria 
were cultured in the presence of the polyphenols (Fig. 4C). These data suggest that polyphenols affected the 
formation of Bap amyloid-like aggregates.
Figure 2.  Antibiofilm activity of polyphenols against 3 non-related S. aureus strains that express Bap (C104, 
V858 and Newman-Bap) and other staphylococcal species (S. hycus, S. simiae and S. saprophytycus) that form 
Bap-dependent biofilms. MBIC were used as 10 μg/ml for quercetin (QC), 10 μg/ml for myricetin (MC) and 
5 μg/ml for scutellarein (SC). 2% of DMSO was added as control (Ø). Bacteria cultured in TSB-glu media 
were used as positive control (−). Crystal violet was quantified by measuring absorbance at 595 nm. Statistical 
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Figure 3.  Biofilm growth of S. aureus V329 (a) and 15981 (b) in the presence of polyphenols. Graphs show total 
biofilm mass through time, as determined by impedance measurements in the absence (black line) and presence 
of quercetin (QC) 10 μg/ml, myricetin (MC) 10 μg/ml, scutellarein (SC) 5 μg/ml and baicalein (BC) 10 μg/ml. 
Quantification of biofilm growth was recorded every 10 min at 37 °C. Each line represents the mean of three 
biological replicates. For statistical differences in biofilm CI values, regression analysis was assessed by a linear 
model between 15 and 25 h of biofilm growth, using the lm library in the R statistical package version 1.0.7.1. 
(*P < 0.05). SDs are not shown for clarity.
Figure 4.  Western immunoblot showing the effect of polyphenols on the expression and aggregation of Bap. 
(a) GFP protein levels of S. aureus V329 with pCN52-Pbap:GFP plasmid in presence of MBIC of : 10 μg/ml for 
quercetin (QC), 10 μg/ml for myricetin (MC) and 5 μg/ml for scutellarein (SC). (b) Bap protein levels of S. 
aureus V329 in presence of MBICs of polyphenols. (c) Native immunoblotting of cell surface extracts S. aureus 
V329 cultured in presence of MBICs of polyphenols. Bap-related insoluble aggregates are indicated by a dashed 
line box. Untreated bacterial cells were used as positive control (Ø).
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Polyphenols interfere with Bap polymerization process. To test whether the polyphenols hinder 
Bap capacity to generate amyloid aggregates, we used the curli-dependent amyloid generator (C-DAG)  system35. 
When the N-terminal domain of the Bap protein (Bap_B amyloid domain) is heterologous expressed and 
exported in the E. coli strain of C-DAG system it self-assembles into amyloid-like structures (Fig. 5A)17. Aggre-
gates are detected by analyzing the capacity of the resulting strain to bind Congo Red dye (CR). To remove the 
color background of polyphenols, relative CR binding was determined by subtracting the CR value of E. coli 
cells expressing Bap_A, a non-amyloidogenic domain. As shown in Fig. 5B, the relative CR binding of E. coli 
cells cultured in the presence of MBIC of polyphenols (10 μg/ml for QC, 10 μg/ml for MC and 5 μg/ml for SC) 
were significantly lower (**P < 0.01) than the CR binding of E. coli cells grown in the absence of polyphenols. 
Polyphenols caused no inhibition of E. coli growth (Supplementary Fig. S3). Similar results were obtained when 
polyphenols were added to E. coli cells expressing Bap_B domain of S. saprophyticus (Fig. 5B). Furthermore, 
electron microscopy analysis of the E. coli strain exporting the S. aureus Bap_B domain revealed the presence 
of extracellular fibrous aggregates surrounding the cells. However, fibrillar structures were not observed in E. 
coli strain cultured in the presence of polyphenols (Fig. 5C). These results confirmed that polyphenols inhibit 
bacterial amyloid formation.
The polyphenols hinder the formation of rBap_B amyloid polymerization. To investigate 
whether the polyphenols modulate Bap amyloid aggregation independently of additional bacterial factors, we 
measured the capacity of a purified recombinant protein comprising exclusively the B region of Bap (rBap_B) 
to bind Th-T in the presence of polyphenols. The results showed that rBap_B polymerization was significantly 
inhibited in the presence of polyphenols (Fig. 6A). None of the polyphenolic molecules displayed background 
fluorescence in these conditions when they were assayed without the rBap_B protein (Fig. 6B).
To confirm that the polyphenols identified were true aggregation inhibitors and not a misleading artefact 
produced by the displacement of Th-T from amyloid by polyphenols, we used a turbidimetric  assay36. Aggrega-
tion of rBap_B gives rise to high molecular weight aggregates that scatter light and increase the turbidity of the 
solution. Recombinant rBap_B was incubated in the presence of each polyphenolic compound QC, MC and SC 
Figure 5.  Assembly of Bap_B using the curli-dependent amyloid generator (C-DAG) in the presence of 
polyphenols. (a) Representative scheme of C-DAG. Bap_B domain is cloned under the control of the inducible 
PBAD promoter and the signal sequence of CsgA. CsgG is expressed under the control of an IPTG-inducible 
promoter and forms a pore in the OM for externalization of Bap_B. Bap_B forms amyloid-like fibers (left 
panel). Polyphenols (green circles) can interrupt the assembly of Bap_B into amyloid fibers (right panel). Outer 
membrane (OM), cytoplasmic membrane (CM), periplasmic space (PS). (b) Quantification of CR bound to 
E. coli cells expressing Bap_B from S. aureus and S. saprophytycus in the presence of MBIC of polyphenols. Ø, 
without polyphenols. The relative effect of the polyphenols was calculated as  OD500nm Bap_B − OD500nm Bap_A. 
Bars represent standard deviations of the results of five independent experiments (n = 5). Statistically significant 
differences were determined using Mann–Whitney test *P < 0.05. (c) Transmission electron micrographs of 
negatively stained fiber-like structures formed by E. coli cells that express S. aureus Bap_B. Extracellular fibrous 
structures are not observed in the presence of polyphenols.
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for 3 h, and the absorbance at 360 nm was measured over time. The three polyphenols reduced the building of 
turbidity in the rBap_B solution and were considered to be aggregation inhibitors (Fig. 6C).
QC and MC reduce S. aureus colonization of subcutaneous catheters. Bap-mediated biofilm is 
important for the colonization and persistence of indwelling medical devices by S. aureus in  vivo17. Therefore, 
we decided to investigate whether the polyphenols were able to reduce S. aureus colonization of implanted 
subcutaneous catheters in vivo. For this purpose, polyphenols were administered subcutaneously after catheter 
implantation and repeated daily. At day 10, all animals were killed and catheters were extracted for colony-
forming unit (CFU) counting. The results showed that treatment with QC and MC significantly reduced the 
number of bacteria attached to the catheter with percentage reduction of 53% ± 13% and 54% ± 17%, respectively 
(**P < 0.01;***P < 0.001) (Fig. 7). Treatment with SC, slightly reduced the catheter colonization by S. aureus, but 
the reduction was not statistically significant.
Discussion
Several therapeutic alternatives have been proposed to treat medical device-related infections. These include 
the use of effective antibiofilm molecules or substances that dissolve the biofilm  matrix9. Here, we show that the 
polyphenols quercetin (QC), myricetin (MC) and scutellarein (SC) efficiently inhibit the staphylococcal biofilm 
matrix by specifically targeting Bap-like amyloids. Particularly, MC and its derivative QC acts as molecules that 
reduces S. aureus Bap-mediated biofilms using an in vivo catheter infection mice model.
Polyphenols are a group of biologically active secondary metabolites of plants able to disturb the polym-
erization of human amyloids responsible for important disorders by inhibiting toxic amyloid formation and/
Figure 6.  Polyphenols inhibit aggregation of a recombinant rBap_B. (a) Kinetic aggregation of recombinant 
rBap_B protein at 0.1 mg/ml in presence of 200 µM of the polyphenols in phosphate-citrate buffer pH 4.4. 
Th-T amyloid-dye was added and emission spectra were recorded in the range of 460–600 nm. (b) The basal 
fluorescence of polyphenols themselves were recorded. (c) Kinetic aggregation assays of rBap_B in the in 
presence of polyphenols, followed by solution turbidity. Turbidity was measured as absorbance at 360 nm every 
10 min. Black dots: positive aggregation control (only rBap_B).
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or remodeling or degrading amyloid oligomers and  fibrils26,27. The structure similarities between human and 
bacterial amyloids have led to think that polyphenols may affect amyloid-based biofilms. One example is the poly-
phenol epigallocatechin-3-gallate (EGCG) that has been shown to inhibit the oligomerization of multiple human 
amyloids such as amyloid-β37–39, α-synuclein38,40–42, islet amyloid  polypeptide43,44,  huntingtin45, tau  protein46 and 
prion  proteins47, but it is also considered an effective agent for remodeling of bacterial amyloid fibrils as FapC 
in Pseudomonas sp.  strains48, the amyloid proteins P1, WapA and Smu_63c of Streptococcus mutans49, CsgA in 
 Enterobacteria50,51. In staphylococcal species EGCG prevents phenol-soluble modulins (PSM) fibril formation 
and hinders Bap mediated  biofilms17,52,53. These findings support the hypothesis that polyphenols that are capable 
to inhibit human amyloids can be used to prevent staphylococcal biofilm formation by avoiding Bap protein to 
form functional amyloid-like fibers.
Our results showed that QC, MC and SC inhibit S. aureus biofilm formation by targeting Bap amyloids with-
out affecting Bap expression. Although the exact mechanism by which these polyphenols reduce Bap aggregation 
remains unknown it is likely that a direct interaction of polyphenols with different forms of the oligomers could 
impede the polymerization of the fibers. Our Th-T assay confirms that rBap_B aggregation kinetics follows a 
sigmoidal curve with a small lag phase that reflects a rapid nucleation-dependent growth and flavonoids disrupt 
this mechanism. These evidences demonstrate that QC, MC and SC likely bind monomeric Bap_B or early 
oligomers preventing its oligomerization into amyloid fibrils and thus, inhibiting S. aureus biofilm formation.
It is likely that the reason for the inhibitory process of Bap mediated biofilms between the different poly-
phenols is related to the polyphenolic structure. The aromatic rings of polyphenols may interact and compete 
with the prevalent aromatic residues (Phe and Trp) of the amyloids and block the self-assembly process and the 
fiber formation. Furthermore, the hydrophobic hydroxyl groups of polyphenols could bind to the hydrophobic 
residues of amyloid proteins and inhibit  amyloidogenesis54. Thus, the selected flavonoids have 3 phenolic rings, 
at least 3 hydroxyl groups and in all cases 2 of them are vicinal, which are reported to have higher inhibitory 
effects on human amyloid  proteins34. Interestingly, QC and MC are closely related in structure, with only one 
hydroxyl group of difference. The same occurs between SC and BC (Fig. S1). This may explain why these four 
polyphenols had the strongest inhibitory effect against S. aureus V329 biofilm. It is noteworthy that BC is able 
to inhibit both amyloid-like and PNAG-dependent biofilms. On the one hand, BC showed a significant reduc-
tion of an amyloid-like biofilm at sub-MIC concentrations of 20 μg/ml and 10 μg/ml (1/50xMIC and 1/100xMIC). 
On the other hand, it also reduced PNAG-dependent biofilm of S. aureus 15981 at a concentration of 20 μg/ml. 
Although we discarded this polyphenol from this study due to its broad action, the inhibitory effect of BC on 
the two types of biofilms make it a promising candidate polyphenol and it would be worth undertaking more 
detailed studies in the future.
The effect of QC, MC and SC on Bap amyloid assembly was analyzed using the C-DAG system, which provides 
several advantages: (i) it enables the study of molecule modulators of amyloid aggregation under a uniform set of 
conditions, (ii) it allows to screen the effect of anti-amyloid molecules directly against the amyloid domain of a 
protein (Bap_B domain), (iii) it allows independence from the genetic background of S. aureus since Bap protein 
is heterologous expressed in an E. coli strain. We also used the C-DAG system to expand the anti-amyloid effect 
of the polyphenols to the amyloid domains of Bap homologs from staphylococcal coagulase negative. Therefore, 
this methodology could be used to extend the possible antibiofilm effect of polyphenols on other proteins of the 
BAP family or other amyloid proteins.
Microbial amyloids are potential contributors to the infectious  process15,55–57. In the present study we have 
shown that QC and MC, which are closely related in structure, effectively reduced S. aureus colonization in vivo 
Figure 7.  Efficacy of polyphenols in S. aureus biofilm infection model. Two catheters infected with S. aureus 
strain V329 were implanted at the subscapular space of groups of mice (n = 6), followed by subcutaneous 
administration of quercetin (QC) 100 mg/kg, myricetin (MC) 20 mg/kg, scutellarein (SC) 17.5 mg/kg post-
infection and repeated every day for 10 days. Animal were killed and bacteria were recovered from implanted 
catheters and counted. The plots display values obtained from individual catheters and the mean is represented 
by horizontal bars. Statistical significance was determined with one-way ANOVA followed by Dunn’s multiple 
comparison test comparing to mice that received DMSO as control, Ø. (**P < 0.01; ***P < 0.001).
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in a murine subcutaneous catheter infection model. The administration of these molecules may allow to mini-
mize not only the effective doses of each agent but also fight the emergence of drug-resistant bacteria. Bap of S. 
aureus belongs to the Biofilm Associated Protein (BAP) family. Homologous Bap proteins are present in many 
pathogenic bacteria. Our previous results suggest that the mechanism of amyloid-like aggregation might be 
widespread among these  proteins17,20. This assumption opens an exciting line of research to consider BAP proteins 
as molecular targets of polyphenols to fight against biofilm related infections.
Methods
Bacterial strains and growth conditions. S. aureus V329 and 15981 were used as model strains. S. 
aureus V329 isolated from a bovine mastitis expresses Bap and forms amyloid-like biofilms. Deletion of bap 
gene abolishes biofilm formation in this  strain18. S. aureus 15981 is a bap negative clinical isolate that forms poly-
saccharide (PNAG) mediated  biofilms58. Deletion of ica genes responsible of PNAG synthesis, abolish biofilm 
formation in this strain. As Bap positive strains we used: S. aureus  Newman_Bap59; S. aureus  C10460; S. aureus 
 V85861; S. saprophyticus B20080011225, S. hyicus 12 and S. simiae CCM721317. Staphylococcal strains were cul-
tured in trypticase soy broth supplemented with glucose (0.25%, w/v) (TSB-glu).
Polyphenols. The polyphenols listed in Table 1 were obtained from Sigma-Aldrich (purity ≥ 98%; St. Louis, 
USA) and Quimigen. The stock and work solutions of polyphenols were prepared in a mixture of dimethyl sul-
foxide (DMSO). The DMSO that remained after dilution of polyphenol work solutions into culture broth, even 
at the highest tested concentration (2%, v/v) caused no inhibition of bacterial growth (Supplementary Fig. S3).
Determination of minimal inhibitory concentration (MIC). The MIC values of the polyphenols 
against S. aureus V329 were determined using the twofold serial microdilution  method62. The tested compounds 
were added to a 96-well plate containing sterile TSB-glu medium reaching final concentrations of 5–5000 μg/ml. 
Bacterial inoculum in the medium without the tested compound served as a positive control, whereas the tested 
compounds in medium without bacteria served as negative control. Following a 24 h incubation, the bacterial 
growth was evaluated by measuring the turbidity in each well through spectrophotometric analysis (600 nm). 
The lowest concentration that did not produce detectable absorbance values until the end of incubation was con-
sidered as the MIC. All tests were repeated three times to verify the reproducibility of results. Subsequently sub-
MICs values of 1/50xMIC, 1/100xMIC and 1/500xMIC were determined for their capacity to inhibit biofilm formation.
Biofilm inhibition assay. Overnight cultures with  OD600 = 5 (~ 7.5 × 109  CFU/ml) were diluted 1:40 in 
TSB-glu medium with sub-MIC dosages of the polyphenols. To exclude a DMSO effect on biofilm formation, 
overnight culture was diluted in TSB-glu medium with 2% DMSO. Bacteria culture in TSB-glu media was used 
as positive control. 200 μl of this cell suspension were inoculated in 96-wells polystyrene microtiter plates. After 
18 h of incubation at 37 °C, wells were washed with sterile phosphate-buffered saline (PBS) and stained with 
0.1% crystal violet. The optical density at 595 nm of the solubilized colorant was determined using a microplate 
reader (Multiskan EX; Lab-Systems). Each assay was performed in triplicate. Statistical significance differences 
were determined with one-way ANOVA followed by Dunn’s multiple comparison test: *P < 0.05, **P < 0.01, 
***P < 0.001.
Real‑time biofilm growth analysis. Continuous real-time biofilm monitoring was performed using 
xCELLigence RTCA (Real-Time Cell Analysis) equipment (Agilent). This assay is based on the ability of bacte-
ria to impede electric current when they attach and grow on the gold electrodes placed at the bottom of 96-well 
microtiter plates. Bacterial biofilms grown in microtiter plates with electrodes at the bottom of wells impedes the 
flow of electrical current. The impedance is expressed as Cell Index (CI) values, which correlate with the total 
biofilm mass. The experiments were performed as described  previously63,64. Briefly, 100 µl of each polyphenol 
(Table 1) diluted in TSB-glu was used as background for impedance measurements (reaching final concentra-
tions of 10 µg/ml for QC, BC and MC and 5 µg/ml for SC, respectively). Further, 100 µl of S. aureus V329 and 
15981 bacterial suspensions  (OD600 = 0.175) were added into the corresponding wells of a 96-well plate, reach-
ing an initial optical density of 0.0875  (107–108 cells, depending on the strain). Impedance data were registered 
at 10-min intervals for 50 h at 37 °C. Three replicates of each polyphenol and their respective controls were 
included in each experiment, which was repeated three times. In order to study statistical differences in biofilm 
CI values, regression analysis was assessed by a linear model between 15 and 25 h of biofilm growth, using the lm 
library in the R Statistical Package version 1.0.7.1 (Calgano, 2013) (accessed in November, 2019).
SDS‑PAGE and immunoblot assays. Overnight cultures were diluted 1:100 in media supplemented 
with MBIC of polyphenols (Table 1). Bacteria were grown in microtiter plate under static conditions (biofilm 
formation conditions) until exponential  (OD600nm = 0.8) and stationary phase  (OD600nm = 5). For surface protein 
extracts, cells were resuspended in 100 μl of PBS containing 26% w/v raffinose (Sigma) and 3 μl of 1 mg/ml 
lysostaphin and incubated 2 h at 37 °C. For total protein extracts, cells were resuspended in 1 ml of PBS and 
lysed using FastPrep-24 instrument (MP Biomedicals). Supernatants were quantified using Bio-Rad protein 
assay kit. 15 μg and 1 μg of proteins were load on acrylamide gels (7.5% and 12% separation gels; 4% stacking 
gels) and were stained with 0.25% Coomassie brilliant blue R250 as loading controls. For native gels, surface 
proteins were separated in Criterion 3–8% XT Tris–acetate gels and Tris/glycine running buffer (BioRad). Bap 
protein was detected using rabbit polyclonal Anti-BapB diluted 1:5000. Peroxidase-conjugated goat anti-rabbit 
immunoglobulin G diluted 1:5000 (Thermo) was used as a secondary antibody. For detection of GFP, mouse 
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monoclonal anti-GFP diluted 1:5000 (Clontech) and peroxidase-conjugated goat anti-mouse immunoglobulin 
G diluted 1:2500 (Pierce) were used as primary and secondary antibodies, respectively. Full-length gels and blots 
are included as Supplementary Fig. S4.
Inhibition of Bap polymerization with the C‑DAG system. We used E. coli VS39 strain with the 
pExport plasmid containing region Bap_B of S. aureus and S. saprophyticus fused to  ssCsgA17,35. Strains were 
grown overnight in LB supplemented with ampicillin, 100 µg/ml and chloramphenicol, 20 µg/ml. The overnight 
cultures were diluted to an OD of 0.01 in LB supplemented with the same antibiotics. To induce CsgG, isopropyl 
B-d-thiogalactopyranoside (IPTG) was added to a final concentration of 1  mM. Cultures were incubated at 
37 °C and 200 rpm until  OD600nm reached 0.03 and then L-arabinose was added to a final concentration of 0.2% 
(w/v). Two milliliters of the cultures were transferred to a 24-well plate containing the MBICs of the polyphe-
nols: QC 10 μg/ml, MC 10 μg/ml and SC 5 μg/ml (Table 1). Bacteria were grown overnight at 37 °C under static 
conditions. Bap_B aggregation capacity was assessed by evaluating the amount of Congo Red (CR) dye bound to 
the cells. Bacterial pellets were stained with Congo Red solution (1.2 ml/l of a 0.8% (w/v) for 10 min. Colorant 
was solubilized in ethanol:acetone (80:20 v/v) during 1 h at 44 °C. The relative effect of the polyphenols was cal-
culated as  OD500nm Bap_B—OD500nm Bap_A (negative control). Independent experiments were performed five 
times. Statistical significance differences were determined using Mann–Whitney test *P < 0.05.
Microscopy analysis. For transmission electron microscopy, cells were grown overnight in the corre-
sponding tested conditions, washed twice with PBS and then fixed with 2% (v/v) paraformaldehyde (Sigma) for 
1 h at room  temperature48. Formvar/carbon-coated nickel grids were deposited on a drop of fixed sample during 
five minutes and rinsed three times with PBS. Negative staining was performed using 2% (v/v) uranyl acetate 
(Agar Scientific, Stansted, UK). Observations were made with a JEOL 1011 transmission electron microscope.
Thioflavin T binding. rBap_B protein at 0.1 mg/ml was incubated in phosphate-citrate buffer pH 4.4. in 
a 96-well plate Nunc™ F96 MicroWell™ (ThermoFisher Scientific) with 200 µM of each polyphenol (Table 1). 
Before measuring thioflavin-T (Th-T) was added at the final concentration of 25 µM. Fluorescence emission 
spectra were recorded in the 460–600 nm range with an excitation wavelength of 445 nm using a 5 nm slit width 
for excitation and emission at 25 °C in the multi-mode reader Synergy H1 Hybrid Multi-Mode Reader.
Turbidity test. Turbidity test was used to discriminate false positives identified at the Th-T assay. For this 
purpose, rBap_B at 0.1 mg/ml was incubated in phosphate-citrate buffer pH 4.4 in the presence of polyphenols: 
QC 10 μg/ml, MC 10 μg/ml and SC 5 μg/ml. Mixture was incubated in a 96-well plate at 37 °C for 200 min and 
the absorbance was measured every 10 min at 360 nm. Every polyphenol was tested in triplicate. Recombinant 
protein without polyphenols was used as a positive control.
Murine model of catheter‑associated biofilm formation. Bacteria grown overnight on TSA plates 
were resuspended in PBS to an OD 0.2  (108 CFU/ml). Groups of five-weeks old ICR female mice (n = 6) (Envigo) 
were anesthetized with isoflurane. Two 19 mm intravenous catheters (24G; B. Braun) were implanted into the 
subcutaneous interscapular of each mouse and inoculated with 100  µl of S. aureus V329. Polyphenols were 
administered subcutaneously at the interscapular space during 10  days at non-toxic concentrations of QC 
100 mg/kg, MC 20 mg/kg and SC 17.5 mg/kg65–68. After 10 days, animals were anesthetized by isoflurane inhala-
tion followed by euthanatized by cervical dislocation. Catheters were removed and placed in a sterile microcen-
trifuge tube containing PBS and vortexed at high speed for 3 min. 25 µl of serial dilution bacteria were plated 
on TSA and incubated overnight at 37 °C for colony formation units (CFUs) count. Sample size calculation has 
been carried out using the IVS program. No criteria were established for excluding animals. Confounders were 
not controlled. Statistical significance differences were determined with one-way ANOVA followed by Dunn’s 
multiple comparison test: **P < 0.01, ***P < 0.001.
Ethics statement. All animal studies were reviewed and approved by the Comité de Ética para la Experi-
mentación Animal (CEEA) of the Universidad de Navarra (approved protocol 114-17). Work was carried out at 
CIMA (ES312010000132) under the principles and guidelines described in European Directive 2010/63/EU for 
the protection of animals used for experimental purposes.
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